Because BAs are critical regulators of fat absorption and hepatic lipid and glucose metabolism, it is rational to consider that BA and BA-related molecules (e.g., FXR, TGR5, FGF19) contribute to microbiota-associated protection against NAFLD. The gene discussed is GPBAR1; the disease is metabolic dysfunction-associated steatotic liver disease.